TYRONE NIEVES-MARTINEZ: Open Payments
NPI 1639924830 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 53 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $785 · 2025 $1,441
Food & beverage: $1,360Education: $81
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $252 |
| ABBVIE INC. | 12 | $200 |
| Regeneron Healthcare Solutions, Inc. | 4 | $165 |
| ViiV Healthcare Company | 4 | $104 |
| Novo Nordisk Inc | 4 | $89 |
| PFIZER INC. | 4 | $88 |
| Amgen Inc. | 3 | $68 |
| Lilly USA, LLC | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
Products named: NEMLUVIO, DUPIXENT, APRETUDE, OTEZLA, MOUNJARO, Kerendia, NURTEC ODT, Rhapsido.
Industry payments across GA — which companies pay providers there.
